BAC Transgenic Expression of Human TREM2-R47H Remodels Amyloid Plaques but Unable to Reprogram Plaque-associated Microglial Reactivity in 5xFAD Mice.

C Y Daniel Lee,Amberlene J De La Rocha,Kellie Inouye,Peter Langfelder,Anthony Daggett,Xiaofeng Gu,Lu-Lin Jiang,Zoe Pamonag,Raymond G Vaca,Jeffrey Richman,Riki Kawaguchi,Fuying Gao,Huaxi Xu,X William Yang

DOI: https://doi.org/10.1101/2023.08.03.551881

2023-01-01

Abstract:Our study demonstrated that the AD-risk variant has a previously unknown, mixture of partial and full loss of TREM2 functions in modulating microglial response in AD mouse brains. Together, our new BAC-TREM2-R47H model and prior BAC-TREM2 mice are invaluable resource to facilitate the therapeutic discovery that target human TREM2 and its R47H variant to ameliorate AD and other neurodegenerative disorders.